Serum Institute of India (SII) is set to begin from today. Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.Human clinical trial process at the Bharati Vidyapeeth Medical College, PuneThe study to determine the safety and immunogenicity of ''Covishield'' on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune from today."We have got all approvals from the Central Drugs Standard Control Organisation (CDSCO).